• Thanongsak, W., Kawahara, M., Nakamoto, M., Homma, K., Sereemaspun, A., Tachaboonyakiat, W., Ruktanonchai, U., Yoshimoto, K., Katayama, R., Matsusaki, M. and Chirachanchai, S.
  Concerted pH-responsive performance of chitosan-deoxycholic acid as a polymeric molecular block for cancer cell disruption.
  ChemMedChem, 21, e202500587 (2026)
• Izumi, H., Sakamoto, T., Uchibori, K., Nishino, K., Sakakibara-Konishi, J., Katayama, R., Nomura, S., Matsumoto, S., Udagawa, H., Shibata, Y., Sakai, T., Nosaki, K., Zenke, Y., Yoh, K., Niho, S. and Goto, K.
  Phase 1/2 trial of brigatinib plus panitumumab in patients with osimertinib-resistant EGFR-mutated non-small cell lung cancer harboring EGFR C797S mutation.
  Cancer Treat. Res. Commun., 46, 101105 (2026)
• Wakita, M., Ito, K., Fujii, K., Sakamoto, D., Mikawa, T., Sugawara, S., Zhou, X., Park, J. H., Miyagawa, H., Motooka, D., Ogasawara, E., Ishihara, N., Takahashi, A., Kondoh, H. and Hara, E.
  Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance.
  Nature aging, in press (2026)
• FuKoichi, J., Kitamura, K., Kawahara, R., Shihoya, W., Nureki, O., Hosoya, S., Nakagawa, R., Mashima, T., Itoh, H., Inoue, M. and Sakurai, K.
  Photoaffinity labeling strategy reveals tetraspanin CD9 as a transient target of anticancer Yaku’amide B.
  J. Am. Chem. Soc.,  in press (2026)
• Moroishi, K., Nakamoto, M., Fujita, S., Kawahara, M., Katayama, R. and Matsusaki, M.
  Escape from cell uptake: Drug-free cancer therapeutics regulated by hydrophobicity and negative charge.
  Mater. Today Bio, 102752 (2025)

more